The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
gixer
sure, to me it says the social network marketing - e.g. Facebook and other marketing initiatives have been pretty ineffective as individuals don't buy 400 at a time. On the flip side, with the likes of amazon regularly being out of stock, also could be all that is available is being sold
W?
The monthly order numbers seem to be pretty constant over the last year or so although subscriber numbers are at an all-time high level as reported in the interim results.
What we cant see in the graph is the Holland & Barrett and the Chinese Distributor order quantities.
If, for example, the Chinese distributor ordered 400 packs. Would this increase the order numbers by 1 or would it be a different system for H&B and China?
Updated plot of change in order number each month
https://postimg.cc/ft63cqNw
Wbored
As long as the sp increases ,it would be nice
I guess they needed the extra .9 m2 for the dustbin?
Checked the times and it did line up with the introduction of the new dietary supplement regulation. Must be why it was canned.
Currently, JuneYao food (Quzhou) Co., Ltd. plans to invest 400 million yuan, (39 Braun Road Quzhou green industry cluster number, see Annex 3) in the open The Zhejiang Sheng Investment Group Co., Ltd. to provide new factories, office buildings and so on milk beverage production facilities. Project land area 66660.9m2, after the completion of an annual output of 180,000 tons can be formed"Taste power"Lactic acid bacteria beverages and"Qin drink"Lactic acid drinks water production capacity, annual sales income of 1.5 billion yuan, profits of 165 million yuan, with good economic returns.
The Qin Drink by Werdery was launched a good while back in China. Following a successful launch it just disappeared. At the time they had submitted planning permission of a new factory to produce the drinks at massive volume. I think that likely got affected by the new regulation in China for dietary supplements.
I think there is a chance that this may re-appear when BH has regulatory clearance in place. Hope so, as the projected volumes were rather exciting.
Your fears don't appear to have put By-Health off at all so I think I will hold for now :)
You are quite right Gixer I could not have been taking FF for 13 years , lets say it was the poetic licence of the less patient . I do admire the fans of PXS that think it will all come good , in a fair world it should but we know what big pharma are like. China is now in turmoil over the housing market collapse , the middle classes wealth will be shrinking fast.
https://fit4you.sk/en/obchod/fit4you-slim-coffee/
https://fit4you.sk/en/obchod/fit4you-senior-plus/
Translated links didn't seem to show the products?
Another from FIT4YOU. Slim Coffee.
https://fit4you-sk.translate.goog/en/obchod/fit4you-slim-coffee/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
The one we already knew about was Senior Plus
https://fit4you-sk.translate.goog/en/obchod/fit4you-senior-plus/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
'Tevva
not seen this share in a long long time, i remember when this was the next cure for cancer and peaked at 21p!, i got lovely little day trade out of that and loads got locked in, thats aim market and reason i dont trade it anymore. Always a gamble and always getting tapped up by the BOD's for share issues and consolidations. To many good quality shares out there to be messing with aim, saying that i am surprised to still see this share here so something good must have come out of it?
ATB ND
You seem to have three options Nazir - Sell, Hold or Buy.
Not sure what you hope to get from the constant whining.
Will be looking to top up here when not focusing elsewhere.
Hopefully next few years we will start to realise potential, but if not will just hold or buy more.
From last years results.
"Commercialisation
Due to the terms of the Alliance Agreement, Provexis is largely dependent on DSM in respect of the
development, production, marketing and commercialisation of Fruitflow. Fruitflow is solely reliant on DSM
under the terms of the Alliance Agreement for its commercialisation."
As Gix says, it has been and remains the responsibility of DSM to market FF. They mainly focus on selling the science to other businesses and providing them with the information to market their own products. There are maybe 150 products out there? and a large prospective pipeline of other businesses potentially launching products. So it has worked, but perhaps not at the pace we hoped for.
In 2023 PXS will control FF and should be in profit and have money to spend. Will they focus on end customers or businesses? Hopefully a bit of both.
Another down day
For the last 12 years its been the responsibility of DSM for sales and marketing of Fruitflow.
Provexis launched Fruitflow + in June 2016 and has had some advertising in the media in that time to include National Radio, local and national Press and magazines social media and YouTube etc. All done on a tightly managed budget so any expected T.V. advert during Coronation Street was never going to be an option.
Sirco was relaunched by Multiple marketing in 2009 so was not the responsibility of PXS to advertise at that time.
2023 will be the time for Provexis to market Fruitflow.
Just for interest.
The first supplement available was Swanson (August 2011) in the U.S. but don't remember when any supplement was available in the U.K.
If you were taking Sirco 13 years ago it would probably have cost you more than £15 a month. If my memory is correct???
Gixer i have spent getting on for £2.3 K on FF (£15 a month for 13 years ish ) not once in that time has PXS put an Ad anywhere that would make an impact , instead they send emails to the already converted , it is PATHETIC .
If anyone on here has had any success at converting anyone to FF then please share your success stories , I am sure I and IF will learn something from them since we both have a rubbish record at promoting FF , and yes he will be reading this BB as he has little else to do for his £100K plus share hand outs.
Very disappointing share
Seems to relate to this study/publication.
https://www-fx361-com.translate.goog/page/2019/1205/6076972.shtml?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
No idea why its popped up again.
Not sure how old, but good to see FF is a non mutagenic
https://www-webapitool-com.translate.goog/info/2507750?_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc&_x_tr_sch=http
Link
https://finance.sina.com.cn/stock/relnews/dongmiqa/2022-07-19/doc-imizmscv2531369.shtml
July 19, 2022
Investors questions:- (to by-health)
"Hi! I know that the company is currently researching products such as pcc1, NAD+, qingluoxin" (Fruitflow) "etc. Some products have even been researched for seven or eight years. Can the company give a deadLine in this regard, and can it be in the theoretical stage?"
Answer:-
"Hello! There are uncertainties in the commercialization cycle of related products based on prospective basic research results, which are related to domestic health food-related regulations and policies. Thanks for attention."
You can't blame them for trying :)